Severe eosinophilic asthma awareness is on the rise, but a new GSK/Harris Poll survey reveals gaps for docs and patients, says GSK senior medical lead.
GlaxoSmithKline enlisted Harris Poll for a severe asthma survey — results point to more outreach
People with certain chronic conditions are faring worse than others during the pandemic. A new survey from The Harris Poll commissioned by GlaxoSmithKline finds that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
